Why the study?
Is the CYP11B2 -344C/T polymorphism associated with an increased risk of essential hypertension in Chinese populations?
Is the CYP11B2 -344C/T polymorphism associated with an increased risk of essential hypertension in Chinese populations?
The CYP11B2 -344C/T polymorphism (specifically the CC genotype and C allele) is significantly associated with essential hypertension in Chinese populations.
Answers are grounded in this paper and cite their sources.
May inform risk stratification in Chinese patients; extends meta-analytic confirmation of CYP11B2 association in East Asians.
A thymidine-to-cytosine substitution in the -344 promoter region of the aldosterone synthase gene (CYP11B2) has been associated with essential hypertension in some but not all studies conducted in Chinese. We performed a meta-analysis to evaluate the association of the -344C/T polymorphism with essential hypertension in Chinese. A total of 7,472 individuals (4,259 unselected hypertensive patients and 3,213 normotensive controls) from 9 case-control studies were included in the present investigation. Significant associations between the risk of hypertension and the CC genotype and C allele frequencies were found in a total of 19 studies. Our findings support the notion that the CYP11B2 -344C/T polymorphism is associated with essential hypertension. In addition, C allele frequency was found to be lower in southern Chinese controls than in their northern counterparts, and the higher TT genotype homozygous frequency in the southern Chinese supports the hypothesis that the northern Chinese are of southern origin.
No takes yet. Share an insight, caveat, or question.
Cheng et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: